Scott Garland, PACT Pharma CEO
PACT Pharma suspends sole clinical trial
Editor’s note: Following additional editorial review, this article and headline have been corrected to reflect that the 51 affected employees highlighted in the California WARN …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.